Elmiron Side Effect May Cause Permanent Life-Altering Vison Problems

Elmiron patients can expect their vision to worsen earlier in life than expected and also long after they have stopped taking the drug

Monday, November 16, 2020 - Pentosan polysulfate sodium (PPS) sold under the brand name Elmiron, is a drug that is to be taken three times per day with food, day after day forever, to treat the pain and discomfort of interstitial cystitis (IC), "a chronic, progressive and debilitating urinary bladder disease afflicting primarily women. IC is characterized by severe bladder and pelvic pain and urinary frequency," according to its definition provided by Center Watch.com. Elmiron can take months before one knows if the drug is working or not, unlike others that show signs immediately. "Relief from the symptoms of IC sometimes takes as long as three months to occur, and subjects must remain on Elmiron for continuing benefit. IC is a unique condition. Since 1996, Elmiron has been the only FDA-approved drug on the market to treat the disease. Johnson & Johnson, the maker of Elmiron, has had a monopoly and has earned tens of millions of dollars in profits. Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is accused by plaintiffs who have developed macular degeneration (MD) from taking the drug and have filed lawsuits seeking compensation for monetary damages and punitive awards. If you or a loved one have developed macular degeneration and have been taking Elmiron, you should contact an Elmiron Eye Damage Lawyer for legal guidance that may lead to filing a claim against Janssen Pharmaceuticals and Johnson & Johnson.

The problems that Elmiron causes IC patients continue long after they stop taking the drug. Patients that have complained to the US Food and Drug Administration (FDA) and also those that have filed lawsuits against Janssen Pharmaceuticals, claim the drug causes permanent eyesight damage such as blurred vision, difficulty adjusting to changes in light, and problems reading, that may continue to worsen if the patient stops taking the medicine. One recent scientific study claims that one's eyesight may continue to degenerate for up to ten years after stopping Elmiron. Plaintiffs claim that their lives have been irreparably and permanently harmed by the eyesight damage allegedly caused by taking Elmiron including not being able to hold a job or maintain normal family and spousal relationships.

Recently, the US Food and Drug Administration reacted to reports of Elmiron patient complaints of eyesight damage by forcing Janssen Pharmaceutical to update the Elmiron product Warnings and Precautions, and Adverse Reactions warning label to include "retinal pigmentary changes, otherwise known as pigmentary maculopathy." Such a measure was too little, too late for millions of Elmiron users that may have experienced the side effect of MD. Johnson & Johnson did little to test and nothing to warn their consumers of the eyesight damage the drug was doing for over two decades. The FDA recommends all those that have taken Elmiron undergo "optical coherence tomography (OCT) and auto-fluorescence imaging" to check for the earliest development of MD.

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.